You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Authors’ response
  1. Rajarshi Mukherjee1,
  2. Christine A Kiire1,
  3. Neil Ruparelia2,
  4. David Keeling3,
  5. Bernard Prendergast2,
  6. Jonathan H Norris1
  1. 1 Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK
  2. 2 Department of Cardiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK
  3. 3 Department of Haematology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK
  1. Correspondence to Jonathan H Norris, Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford OX3 9DU, UK; jonathan.norris{at}ouh.nhs.uk

https://doi.org/10.1136/bjophthalmol-2014-305527

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Grzybowski et al for their comments on our paper.1 The main contention of the authors is that patients undergoing cataract surgery with antiplatelet (Ap) and/or anticoagulant (Ac) medications should continue to receive these drugs based on evidence in the medical literature.

    In our paper, we clearly acknowledge that the predominant technique for lens extraction is phacoemulsification, and that the risk of complications related to bleeding is rare. In one of the papers2 referenced by Grzybowski et al, a small, but not insignificant, risk of intraoperative haemorrhage in patients undergoing cataract surgery is mentioned, with …

    View Full Text

    Footnotes

    • Contributors RM and CAK contributed to the design of the manuscript, acquisition of the data, drafting of the work and approval of the final manuscript. NR and BP contributed to the antiplatelet section including the design, drafting and final approval. DK contributed to the anticoagulant section including the design, drafting and final approval. JHN was the overall in-charge of the work. He conceptualised the project, contributed to the design and drafting of the work and was responsible for final approval of the whole of the manuscript. He is the corresponding author for this article.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles